
EQL Pharma Investor Relations Material
Latest events

Q4 24/25
EQL Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from EQL Pharma
Access all reports
EQL Pharma AB engages in the development, marketing, and sale of specialty and generic medicines to pharmacies and hospitals in Europe. It specializes in the treatment of male infertility by proactive production and sale of medicines under its owned trademarks to end consumers, private actors as well as public hospitals and pharmacies. The company was founded in 2006 and is based in Lund, Sweden.
Key slides for EQL Pharma


CMD 2025
EQL Pharma


ABGSC Investor Days
EQL Pharma
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
EQL
Country
🇸🇪 Sweden